Compare Novavax Inc (NVAX) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs 22nd Century Group Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: Novavax Inc is far larger — about 872.5× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.
| NVAX | XXII | |
|---|---|---|
Market Cap | $1.30B | $1.49M |
Sector | Health | Technology |
52-Week High | $11.19 | $1.07K |
52-Week Low | $6.22 | $3.90 |
Enterprise Value | $800.50M | -$6.74M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
